Wall Street Week: China’s Trade Reckoning, Syracuse’s Second Chance, Humanoids in Healthcare


CFR’s Michael Froman on China’s export strategy and US pressure; Micron’s $100B factory may revive Syracuse; US–Canada trade tensions; humanoid robots as a potential fix for looming long-term care shortages.

Editorial companion

What stands out

Michael Froman lays out how China’s export engine has stayed resilient despite two decades of US pressure, tracing policy, industrial policy, and diplomatic friction into a picture of slow-moving change rather than sudden rupture. The segment on Micron’s planned $100 billion factory in Syracuse turns a finance story into a civic one, asking whether a single large-scale chip plant can remap a local economy. The humanoid-in-healthcare piece connects a looming care-worker shortfall to early robotics plays, making technology a practical labor-supply story rather than a sci-fi thought experiment.